Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,632 | -16,746 | -7,980 | -17,242 | -8,617 |
| Depreciation Amortization | 88 | 124 | 62 | 96 | 55 |
| Other Working Capital | -1,696 | -552 | 1,684 | -1,582 | -5,188 |
| Other Operating Activity | 417 | 15,648 | 6,634 | 3,030 | 2,358 |
| Operating Cash Flow | $-6,823 | $-1,526 | $400 | $-15,698 | $-11,392 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -19 | -14 | 0 | N/A |
| Sale Of Investment | 2,886 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -52 | 0 | -1,253 | -254 |
| Investing Cash Flow | $2,880 | $-71 | $-14 | $-1,253 | $-254 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,408 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -48 | 4,505 | -69 | 40 | -37 |
| Financing Cash Flow | $7,360 | $4,505 | $-69 | $40 | $-37 |
| Exchange Rate Effect | 110 | -367 | -370 | -28 | 158 |
| Beginning Cash Position | 3,724 | 1,183 | 1,183 | 18,122 | 18,122 |
| End Cash Position | 7,251 | 3,724 | 1,130 | 1,183 | 6,597 |
| Net Cash Flow | $3,527 | $2,541 | $-53 | $-16,939 | $-11,525 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,823 | -1,526 | 400 | -15,698 | -11,392 |
| Capital Expenditure | -6 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -6,829 | -1,526 | 400 | -15,698 | -11,392 |